Ditchcarbon
  • Contact
  1. Organizations
  2. Assertio Holdings, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated a month ago

Assertio Holdings, Inc. Sustainability Profile

Company website

Assertio Holdings, Inc., commonly referred to as Assertio, is a prominent biopharmaceutical company headquartered in the United States. Founded in 2013, Assertio has established itself within the specialty pharmaceutical industry, focusing on the development and commercialisation of innovative treatments for pain management and neurology. With a strong operational presence across North America, Assertio is renowned for its unique portfolio of prescription medications, including its flagship product, Zipsor, which offers a novel approach to pain relief. The company has achieved significant milestones, including strategic acquisitions that have bolstered its market position and expanded its therapeutic offerings. Assertio's commitment to improving patient outcomes through targeted therapies underscores its reputation as a leader in the biopharmaceutical sector.

DitchCarbon Score

How does Assertio Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Assertio Holdings, Inc.'s score of 25 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.

37%

Let us know if this data was useful to you

Assertio Holdings, Inc.'s reported carbon emissions

Assertio Holdings, Inc., headquartered in the US, currently does not have available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges. This lack of data suggests that Assertio Holdings may be in the early stages of developing its climate strategy or reporting framework. As of now, there are no emissions inherited from a parent company, and all data is sourced directly from Assertio Holdings, Inc. Without specific emissions figures or reduction initiatives, it is challenging to assess the company's climate commitments or performance in relation to industry standards.

How Carbon Intensive is Assertio Holdings, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Assertio Holdings, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Assertio Holdings, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Assertio Holdings, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Assertio Holdings, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Assertio Holdings, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Assertio Holdings, Inc.'s Emissions with Industry Peers

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Coherus BioSciences, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Acorda Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

INSYS Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251119.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy